header

Medical affairs

Elekta Medical Affairs works closely with the medical community in order to better understand and to internally communicate the needs of the patient and of the practitioner. This insight drives research and development and helps to advance radiotherapy and stereotactic neurosurgery.

By becoming trusted scientific partners in international research collaborations, we are committed to secure, efficient data sharing through data registries. These collaborations lead to the discovery of clinical evidence that supports new, safe and effective uses of radiotherapy for the treatment of cancer and neurological disorders.

 

What's new

  • The automation of the planning process for lung SBRT using robust templates and multicriterial optimization (MCO) was demonstrated to be feasible and more efficient in a report by Marrazzo, L. et al.

    Marrazzo, L., et al. (2020). "Automated planning through robust templates and multicriterial optimization for lung VMAT SBRT of lung lesions."
    J Appl Clin Med Phys.
    https://doi.org/10.1002/acm2.12872

  • The first report (Mazzola, R et al) documenting treatment of older cancer patients with 1.5 T MRI-guided daily-adapted SBRT shows that treatment is feasible, safe and does not impact on the quality of life.

    Mazzola, R., et al. (2020). "Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes."
    J Cancer Res Clin Oncol.

  • First clinical experiences with a high field 1.5 T MR linac are reported by Bertelsen AS, et al, on 19 patients who completed treatment. Cases vary from prostate treatments (60Gy/20F) to SBRT treatments of lymph nodes (45 Gy/3F) and ovarian castration by ovarian irradiation (15 Gy/3F). MRL treatments, including daily MRIs, plan adaptation, and accurate dose delivery, were found to be possible within a clinically acceptable timeframe and well tolerated by the patients.

    Anders S. Bertelsen, et al (2019): First clinical experiences with a high field 1.5 T MR linac
    Acta Oncologica
    DOI: 10.1080/0284186X.2019.1627417

 

THIS CONTENT IS FOR SCIENTIFIC AND EDUCATIONAL PURPOSES - NOT FOR SALES OR PROMOTIONAL USAGE

 

Elekta Medical Affairs activities include

  • Organize and host customer research collaborations
  • Research and write clinical evidence reports
  • Attend major scientific meetings
  • Provide internal and external education

Case studies


These documents will open in new tabs. Please close the tab to get back to this listing.

Clinical presentations

Bibliographies

Ask Medical Affairs